Loading...

China Oncology

30 August 2022, Volume 32 Issue 8
Cover and contents

2022 Issue 8 Cover

Abstract ( 206) PDF (3146KB) ( 400 )

Contents of Issue 8, 2022

2022, 32 (8): 2-2.

Abstract ( 119) PDF (10551KB) ( 364 )

Specialists' Commentary

New research advances and future prospect in precision treatment of triple-negative breast cancer

XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin

2022, 32 (8): 669-679. doi: 10.19401/j.cnki.1007-3639.2022.08.001

Abstract ( 916) PDF (1250KB) ( 2770 ) HTML ( 1418 )

Precise regional management of breast cancer in the sentinel lymph node era: evolution and prospect

QIU Pengfei, WANG Yongsheng

2022, 32 (8): 680-687. doi: 10.19401/j.cnki.1007-3639.2022.08.002

Abstract ( 491) PDF (1101KB) ( 1938 ) HTML ( 377 )

Advances of liquid biopsy in precision treatment of breast cancer

ZHANG Yu, LIU Qiang

2022, 32 (8): 688-697. doi: 10.19401/j.cnki.1007-3639.2022.08.003

Abstract ( 567) PDF (1237KB) ( 1972 ) HTML ( 103 )

New research progress of microwave ablation in the local precise treatment of early-stage breast cancer: the prospect of combined immunotherapy is promising

ZHOU Wenbin, XIE Hui, DING Qiang, WANG Shui

2022, 32 (8): 698-704. doi: 10.19401/j.cnki.1007-3639.2022.08.004

Abstract ( 473) PDF (1164KB) ( 1733 ) HTML ( 50 )

Article

Factors-associated with short-term effect and long-term survival of ovarian function suppression in estrogen receptor positive breast cancer: a retrospective analysis

LIU Yiming, FAN Lei, MO Miao, SHAO Zhimin, YU Keda

2022, 32 (8): 705-711. doi: 10.19401/j.cnki.1007-3639.2022.08.005

Abstract ( 446) PDF (1099KB) ( 1662 ) HTML ( 108 )

Predictive value of sST2 level in immune-related adverse events

XU Yuchen, CHENG Leilei, WANG Yan, LIN Jinyi, CHEN Jiahui, CHEN Yifan, ZHOU Yuhong, LIU Tianshu, GE Junbo

2022, 32 (8): 712-718. doi: 10.19401/j.cnki.1007-3639.2022.08.006

Abstract ( 301) PDF (1047KB) ( 1668 ) HTML ( 34 )

The effect of the interaction between body mass index and age on the prognosis of breast cancer

XIAO Jialong, MO Miao, ZHOU Changming, WANG Zezhou, SHEN Jie, YUAN Jing, YU Keda, LIU Guangyu, WU Jiong, SHEN Zhenzhou, SHAO Zhimin, ZHENG Ying

2022, 32 (8): 719-726. doi: 10.19401/j.cnki.1007-3639.2022.08.007

Abstract ( 467) PDF (1134KB) ( 1771 ) HTML ( 71 )

Predictive value of plasma long non-coding RNA H19 in neoadjuvant therapy for breast cancer

CHEN Anli, SHEN Haoyuan, YANG Shixiong, DENG Chunyan, HU Chaohua, LIU Hanzhong, WANG Shu, QIAN Fang

2022, 32 (8): 727-735. doi: 10.19401/j.cnki.1007-3639.2022.08.008

Abstract ( 305) PDF (1391KB) ( 776 ) HTML ( 65 )

Review

Research progress of ALK kinase domain drug resistance mutation and its future countermeasures

HE Liyuan, WANG Yudong

2022, 32 (8): 736-746. doi: 10.19401/j.cnki.1007-3639.2022.08.009

Abstract ( 688) PDF (1240KB) ( 1097 ) HTML ( 368 )

Guideline and Consensus

Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)

The Society of Gynecological Cancer of China Anti-Cancer Association, Multidisciplinary Diagnosis and Treatment (MDT) Committee of China Anti-Cancer Association, Multidisciplinary Cancer Diagnosis and Treatment Committee of Chinese Medical Doctor Association

2022, 32 (8): 747-756. doi: 10.19401/j.cnki.1007-3639.2022.08.010

Abstract ( 617) PDF (1152KB) ( 1519 ) HTML ( 806 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat